The estimated Net Worth of Bruce Slovin is at least $8.04 Million dollars as of 17 May 2017. Bruce Slovin owns over 15,000 units of SIGA Technologies Inc stock worth over $1,458,194 and over the last 21 years Bruce sold SIGA stock worth over $6,583,650.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bruce Slovin SIGA stock SEC Form 4 insiders trading
Bruce has made over 21 trades of the SIGA Technologies Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Bruce exercised 15,000 units of SIGA stock worth $112,650 on 17 May 2017.
The largest trade Bruce's ever made was exercising 54,167 units of SIGA Technologies Inc stock on 16 November 2016 worth over $4,401,068,750. On average, Bruce trades about 14,876 units every 184 days since 2004. As of 17 May 2017 Bruce still owns at least 194,167 units of SIGA Technologies Inc stock.
You can see the complete history of Bruce Slovin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Bruce Slovin's mailing address?
Bruce's mailing address filed with the SEC is C/O SIGA TECHNOLOGIES, INC., 420 LEXINGTON AVENUE, SUITE 408, NEW YORK, NY, 10170.
Insiders trading at SIGA Technologies Inc
Over the last 21 years, insiders at SIGA Technologies Inc have traded over $65,185,125 worth of SIGA Technologies Inc stock and bought 6,065,626 units worth $33,817,674 . The most active insiders traders include Holdings Incperelman Ronald..., Pharma Inc Transtech, and Adnan M M Mjalli. On average, SIGA Technologies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $1,122,865. The most recent stock trade was executed by Dennis E Hruby on 1 July 2024, trading 32,258 units of SIGA stock currently worth $242,258.
What does SIGA Technologies Inc do?
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
What does SIGA Technologies Inc's logo look like?
Complete history of Bruce Slovin stock trades at Daxor and SIGA Technologies Inc
SIGA Technologies Inc executives and stock owners
SIGA Technologies Inc executives and other stock owners filed with the SEC include:
-
Daniel Luckshire,
Chief Financial Officer, Executive Vice President, Secretary -
Dr. Phillip Louis Gomez III, M.D., Ph.D.,
CEO & Director -
Phillip Gomez,
Chief Executive Officer, Director -
Robin Abrams,
Chief Administrative Officer, General Counsel -
Dr. Dennis E. Hruby,
Exec. VP & Chief Scientific Officer -
Dennis Hruby,
Chief Scientific Officer, Vice President -
Daniel J. Luckshire,
Exec. VP, CFO & Sec. -
Robin E. Abrams,
Gen. Counsel & Chief Admin. Officer -
Eric Rose,
Chairman of the Board -
Julie Kane,
Independent Director -
Michael Plansky,
Independent Director -
Joseph Marshall,
Independent Director -
James Antal,
Independent Director -
Thomas Constance,
Independent Director -
Herb Vloedman,
Chief Information Officer -
Tove C. Bolken,
Sr. VP of Operations & Chief Supply Chain Officer -
Diem Nguyen,
Chief Executive Officer -
Larry R. Miller,
General Counsel -
Holdings Incperelman Ronald...,
-
Bruce Slovin,
Director -
Paul G Savas,
-
Jeffrey B Kindler,
-
Scott M Hammer,
Director -
Donald G Drapkin,
Director -
Bernard L Kasten,
Chief Executive Officer -
Ayelet Dugary,
Acting Chief Financial Officer -
Judy S Slotkin,
Director -
Michael Md Weiner,
Director -
Thomas N Konatich,
CFO, Secretary and Treasurer -
Adnan M M Mjalli,
Director -
John Odden,
VP - Business Development -
Ronald O Mac Andrews & Forb...,
-
William C Bevins,
Director -
Susan K Burgess,
President -
Michael J Bayer,
Director -
Frances F Townsend,
Director -
William J Ii Haynes,
Executive VP & General Counsel -
Steven L Fasman,
Director -
Pharma Inc Transtech,
10% owner -
& Forbes Holdings Inc.Perel...,
-
Mehmet C Md Oz,
Director -
Donald G Drapkin,
Director -
Evan A. Knisely,
-
Edward P. Taibi,
-
Holly L. Phillips,
-
Jaymie A Durnan,
-
Gary J. Nabel,
-
Julian Nemirovsky,
-
Harold Eugene Jr. Ford,
-
Jay Varma,
EVP & Chief Medical Officer